comparemela.com
Home
Live Updates
J&J scratches AD itch by acquiring experimental eczema antib
J&J scratches AD itch by acquiring experimental eczema antib
J&J scratches AD itch by acquiring experimental eczema antibody for $1.25B
J&J will pick up Yellow Jersey Therapeutics, a wholly-owned subsidiary of Numab Therapeutics, for $1.25 billion to acquire all assets related to NM26.
Related Keywords
Jersey ,
David Urech ,
David Lee ,
Ambrx Biopharma ,
Johnson ,
Drug Administration ,
Johnson Innovative Medicine ,
Yellow Jersey Therapeutics ,
Numab Therapeutics ,